RECRUITING

Distal Radius Interventions for Fracture Treatment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This protocol describes a multicenter, prospective randomized superiority trial comparing functional outcomes between children treated with sedated reduction versus no formal reduction.

Official Title

Reduction and Nonreduction Treatment of Displaced Pediatric Distal Radius Fractures (Peds-DRIFT Trial - Distal Radius Interventions for Fracture Treatment)

Quick Facts

Study Start:2023-04-09
Study Completion:2028-08-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05131685

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:4 Years to 10 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. Provision of signed and dated informed consent form by parent or legal guardian
  2. 2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. 3. Male or female, aged 4-10 years
  4. 4. Diagnosis of 100% dorsally displaced radius metaphyseal fracture with any or no ulna involvement
  5. 5. Fracture is less than 5cm from the distal radial growth plate
  6. 6. Willing to adhere to the immobilization regimen
  7. 7. Fracture is acute (occurred less than 10 days prior to consent and assignment of treatment arm AND with ability to be taken to operating room (OR) or reduced in the emergency department (ED)
  1. 1. Physeal involvement of fracture
  2. 2. Presence of open fracture, pathologic fracture, neuromuscular disease, or metabolic disease
  3. 3. Fracture cannot be treated with acute reduction due to being older than 10 days
  4. 4. Patient and parents are unable to adhere to procedures or complete follow-up due to insufficient comprehension of consent form or surveys or developmental delay.

Contacts and Locations

Study Contact

Jamie Burgess, PhD
CONTACT
312-227-6531
jburgess@luriechildrens.org
Candace Young, BS
CONTACT
(312) 227-6427
cayoung@luriechildrens.org

Principal Investigator

Jospeh Janicki, MD
PRINCIPAL_INVESTIGATOR
Ann and Robert H. Lurie Children's Hospital of Chicago

Study Locations (Sites)

Phoenix Children's Hospital
Phoenix, Arizona, 85016
United States
Riley Children's
Indianapolis, Indiana, 46202
United States
Johns Hopkins Hospital
Baltimore, Maryland, 21287
United States
Boston Children's Hospital
Boston, Massachusetts, 02115
United States
Gillette Children's Specialty Healthcare
Saint Paul, Minnesota, 55101
United States
Montefiore Medical Center
Bronx, New York, 10467
United States
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, 27599
United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229
United States
University Hospitals Rainbow Babies & Children
Cleveland, Ohio, 44106
United States

Collaborators and Investigators

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

  • Jospeh Janicki, MD, PRINCIPAL_INVESTIGATOR, Ann and Robert H. Lurie Children's Hospital of Chicago

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-04-09
Study Completion Date2028-08-31

Study Record Updates

Study Start Date2023-04-09
Study Completion Date2028-08-31

Terms related to this study

Additional Relevant MeSH Terms

  • Fracture Distal Radius